SOLIGENIX, INC.
جودة البيانات: 100%
SNGX
Nasdaq
Manufacturing
Chemicals
KWD 1.12
▼
KWD 0.02
(-1.75%)
القيمة السوقية: 11.75 M
السعر
KWD 1.14
القيمة السوقية
11.75 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue declined -38.31% annually over 5 years
Negative free cash flow of -10.27 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38.31%
Capital efficient — spends only 4.93% of revenue on capex
النمو
Revenue Growth (5Y)
-38.31%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-235.08%
أقل من متوسط القطاع (-53.47%)
ROIC-187.09%
Net Margin-9282.30%
Op. Margin-9923.24%
الأمان
Debt / Equity
N/A
Current Ratio3.18
Interest CoverageN/A
التقييم
PE (TTM)
-1.06
أعلى من متوسط القطاع (-1.48)
P/B Ratio1.55
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.1 | -1.5 |
| P/B | 1.6 | 1.6 |
| ROE % | -235.1 | -53.5 |
| Net Margin % | -9282.3 | -41.5 |
| Rev Growth 5Y % | -38.3 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
2 محللين
Buy
الحالي
KWD 1.12
المستهدف
KWD 15.00
KWD 10.00
KWD 15.00
KWD 20.00
التوقعات
مكرر الربحية المستقبلي
-1.32
ربحية السهم المستقبلية
-KWD 0.85
الإيرادات المقدّرة
0.0
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.85
-KWD 0.85 – -KWD 0.85
|
0.0 | 1 |
| FY2026 |
-KWD 0.85
-KWD 0.85 – -KWD 0.85
|
0.0 | 1 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.18
-KWD 0.18 – -KWD 0.18
|
0.0 | 1 |
| 2026 Q1 |
-KWD 0.26
-KWD 0.26 – -KWD 0.26
|
0.0 | 1 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.27 | N/A | — |
| Q32025 | -KWD 0.48 | -KWD 0.58 | -20.8% |
| Q22025 | -KWD 1.05 | -KWD 0.82 | +21.9% |
| Q12025 | -KWD 0.67 | -KWD 1.06 | -58.2% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.00% | Revenue Growth (3Y) | -62.29% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -38.31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 119,371.0 | Net Income (TTM) | -11.08 M |
| ROE | -235.08% | ROA | -129.94% |
| Gross Margin | N/A | Operating Margin | -9923.24% |
| Net Margin | -9282.30% | Free Cash Flow (TTM) | -10.27 M |
| ROIC | -187.09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.18 |
| Interest Coverage | N/A | Asset Turnover | 0.01 |
| Working Capital | 7.46 M | Tangible Book Value | 7.60 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.06 | Forward P/E | N/A |
| P/B Ratio | 1.55 | P/S Ratio | 98.42 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -87.43% | ||
| Market Cap | 11.75 M | Enterprise Value | 11.75 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.14 | Revenue / Share | 0.01 |
| FCF / Share | -1.00 | OCF / Share | -1.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 4.93% | FCF Conversion | 92.71% |
| SBC-Adj. FCF | -10.60 M | Growth Momentum | 38.31 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 119,371.0 | 119,371.0 | 839,359.0 | 948,911.0 | 824,268.0 |
| Net Income | -11.08 M | -8.27 M | -6.14 M | -13.80 M | -12.55 M |
| EPS (Diluted) | -2.14 | -4.98 | -0.79 | -4.81 | -0.31 |
| Gross Profit | — | 97,311.0 | 97,311.0 | 398,089.0 | 95,628.0 |
| Operating Income | -11.85 M | -9.44 M | -7.70 M | -14.24 M | -13.14 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 7.49 M | 5.22 M | 3.31 M | 7.94 M | 8.39 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | 34,161.0 |
| Interest Expense | — | — | — | — | -862,577.0 |
| Income Tax | -506,615.0 | -409,114.0 | -1.77 M | -1.15 M | -864,742.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.24 M | 8.97 M | 9.80 M | 14.28 M | 26.87 M |
| Total Liabilities | 3.94 M | 4.85 M | 7.27 M | 16.75 M | 16.15 M |
| Shareholders' Equity | 5.29 M | 4.12 M | 2.52 M | -2.47 M | 10.72 M |
| Total Debt | — | 0.0 | 1.01 M | — | — |
| Cash & Equivalents | — | — | — | — | 26.04 M |
| Current Assets | 8.85 M | 8.83 M | 9.51 M | 13.85 M | 26.57 M |
| Current Liabilities | 3.70 M | 4.85 M | 6.15 M | 16.52 M | 6.29 M |
{"event":"ticker_viewed","properties":{"ticker":"SNGX","listing_kind":"stock","pathname":"/stocks/sngx","exchange":"Nasdaq","country":"US"}}